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The use of CeCl3·7H2O as an efficient and eco-friendly
promoter for the convenient synthesis of methoximes derived
from aromatic aldehydes and ketones, is reported. The
transformations entail the use of equimolar amounts of
MeONH2·HCl and NaOAc in EtOH at 50°C, and no special
precautions are needed with regard to the presence of oxygen.
The scope and limitations of the transformation were studied
and a reaction mechanism was proposed.
1. Introduction
The oxime ether moiety is an important structural motif
found in relatively few natural products [1,2] and in a wide
variety of pharmacologically relevant compounds. These include
some anticonvulsants [3], antimycobacterials and antidepressants
(fluvoxamine) [4], as well as antiparasitic (moxidectin) [5],
antimicrobials (gemifloxacin, cefetamet) [6], antitumorals [7],
enzyme inhibitors [8] (figure 1) and prodrugs, among others [9].
This functional group is also widespread among approved
crop-protecting agents, as exemplified by the synthetic strobilurins
trifloxastrobin and fluoxastrobin, for conferring them valuable
selectivity in their biocidal properties [10].
Furthermore, oxime ethers are frequently present in the
patent literature, being broadly used as intermediates in the
chemical industry and in synthetic organic chemistry [11],
especially for electrocyclization [12,13] and more recently for
2018 The Authors. Published by the Royal Society under the terms of the Creative Commons
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antileishmanial agent antitumour agent
Figure 1. Selected relevant compounds displaying the methoxime motif.
ortho-functionalization reactions of inactive ArC–H bonds [14,15], being also useful as aldehyde and
ketone protecting groups [16] or as chromatographic derivatization agents [17]. In addition, oxime ethers
have been employed as precursors of other functional groups, such as alkoxy-amides/lactams [18],
nitriles [19] and amidines [20].
The methoximes are a special group among the oxime ethers. Conventional methods towards their
synthesis [21] mostly rely on the reaction between methoxylamine and aromatic or aliphatic aldehydes
or ketones [22]. (Hydro)alcoholic media, pyridine [22,23] and, occasionally, chlorinated compounds are
employed as solvents [24]. Refluxing conditions are generally required for improved yields.
Some protocols include the use of molecular sieves, Na2SO4 or MgSO4 as water scavengers, to drive
the reaction to a more rapid completion and/or to avoid heating [25,26]. Usual yields exceed 70%. The
methoximation reagent is available as MeONH2·HCl, which is seldom employed alone; usually, a base
(pyridine, Et3N, NaOAc, NaHCO3, Na2CO3 or K2CO3) is added [27,28], which enables the use of milder
reaction conditions (less time, lower temperature).
Less conventional alternatives have also been reported, such as the O-methylation of oximes with
different alkylating agents [4,29], the use of mineral acids (HCl) [30], stronger bases (NaOH) [31] and
solid catalysts (Amberlyst A-21 [32] or silica gel [33]), under ultrasound [34], microwaves [35] and
mechanochemical [36] promotion.
However, despite the significance of these protocols, most of them require a great excess of
reagents [13], unnecessarily prolonged reaction times or heating under reflux [37], which may




be incompatible with highly functionalized or sensitive compounds. Furthermore, although these
disadvantages are known, the final attainment of reasonable yields after such unfavourable conditions
has conspired against the development of milder procedures towards these widely used compounds.
We have repeatedly used methoximes as synthetic intermediates towards the elaboration of complex
isoquinoline skeletons and have experienced the need of more efficient alternatives towards their
preparation [38–40]. In this context we have observed the beneficial effects of the addition of
CeCl3·7H2O [40].
Not long ago, it was considered that ‘catalytic processes . . . which take advantage of the unique
properties of lanthanides are still rare’ [41, p. 1922]. Therefore, herein, we wish to report the development
of an expedient approach for the methoximation of aromatic aldehydes and ketones, under mild Lewis
acid catalysis by CeCl3·7H2O. Despite the huge advances in catalysis which have taken place during the
last two decades, to the best of our knowledge, promotion of the methoximation reaction has not yet
been described with this handy compound or under any other lanthanide salt.
2. Material and methods
2.1. General information
The reactions were executed employing oven-dried glassware and freshly distilled anhydrous solvents.
Absolute EtOH was obtained by refluxing the analytical reagent solvent with magnesium turnings and a
crystal of iodine, followed by distillation from the so formed magnesium ethoxide. The other anhydrous
solvents were dried according to the conventional procedures [42]. Anhydrous NaOAc was prepared
by careful heating of the trihydrate and drying the so fused salt [42]. All other reagents were used as
received.
The reactions were monitored by thin-layer chromatography (TLC). The chromatographic spots
were detected by exposure to 254 nm ultraviolet light, and by spraying with ethanolic p-anisaldehyde/
sulphuric acid reagent, followed by careful heating to improve selectivity. All new compounds gave
single spots on TLC plates run in different solvent systems (hexanes or hexanes–EtOAc).
The flash column chromatographies were run with silica gel 60 H (particle size 63–200 µm), eluting
with hexane–EtOAc mixtures, under positive pressure and employing gradient of solvent polarity
techniques.
2.2. Apparatus
The melting points were measured on an Ernst Leitz Wetzlar model 350 hot-stage microscope. The
Fourier transform infrared spectroscopy (FT-IR) spectra were recorded on a Shimadzu Prestige 21
spectrophotometer, as solid dispersions in potassium bromide (KBr) disks or as thin films held between
NaCl cells.
The nuclear magnetic resonance (NMR) spectra were acquired in CDCl3 unless otherwise noted,
on a Fourier transform nuclear magnetic resonance (FT-NMR) Bruker Avance 300 spectrometer, at
300.13 (1H) and 75.48 (13C) MHz. The chemical shifts are consigned in parts per million in the δ scale.
Tetramethylsilane was used as the internal standard (resonances of CHCl3 in CDCl3: δ 7.26 and 77.0 for
1H and 13C NMR, respectively). An asterisk (*) designates signals which attribution can be exchanged.
The coupling constants (J) and half-width (w1/2) values are given in Hertz. Some 2D-NMR experiments
(COSY, HSQC) were also performed.
The high-resolution mass spectra were obtained from UMYMFOR (Buenos Aires, Argentina) and
ICYTAC (Córdoba, Argentina) with Bruker MicroTOF-Q II instruments. Detection of the ions was
performed in electrospray ionization, positive ion mode. The gas chromatography-mass spectrum (GC-
MS) runs were carried out in a Shimadzu QP2010 Plus GC-MS instrument. Fragments are described with
regards to their m/z ratios, in terms of relative intensity (%) of their signals. The specific optical rotations
were measured at room temperature, with a Jasco DIP-1000 polarimeter using a microcell (1 cm path
length).
2.3. General procedure for the syntheses of the methoximes 2a–v
A stirred mixture of the aldehyde or ketone (1, 0.30 mmol), MeONH2·HCl (37.5 mg, 0.45 mmol, 1.5
equiv.) and anhydrous NaOAc (37 mg, 0.45 mmol, 1.5 equiv.) in absolute EtOH (2.5 ml) was treated
with CeCl3·7H2O (5.6 mg, 5 mol%), and the reaction was heated to 50°C in a test tube, without special




protection against atmospheric oxygen. The progress of the reaction was monitored by TLC. After
completion, brine (10 ml) was added and the products were extracted with EtOAc (3 × 10 ml). The
organic layers were combined, dried over MgSO4 and concentrated under reduced pressure. The residue
was purified by column chromatography, eluting with mixtures of hexanes and EtOAc.
2.3.1. (1e)-N-Methoxy-1-phenylethanimine (2a) [28]
Colourless oil; yield: 81%. IR (film, υ): 3000, 1647, 1604, 1529, 1497, 1480, 1385, 1325, 1204, 1100, 1085,
1000, 900, 785, 770 and 700 cm−1. 1H NMR: 2.23 (s, 3H, Me), 4.00 (s, 3H, OMe), 7.33–7.40 (m, 3H, H-3′,
H-4′ and H-5′) and 7.60–7.68 (m, 2H, H-2′ and H-6′). 13C NMR: 12.6 (Me), 61.9 (N-OMe), 126.0 (C-2′ and
C-6′), 128.4 (C-3′ and C-5′), 129.0 (C-4′), 136.7 (C-1′) and 154.7 (C-1). Electron ionization-mass spectrum
(EI-MS) (m/z, %): 149 (M+, 59), 134 [(M-15)+, 5], 118 (38), 108 (7) and 77 (100).
2.3.2. (1e)-1-(4-Bromophenyl)-N-methoxyethanimine (2b) [28]
Colourless oil; yield: 80%. IR (film, υ): 2936, 1609, 1587, 1485,1395, 1317, 1084, 1049, 1009, 895 and
824 cm−1. 1H NMR: 2.19 (s, 3H, Me), 3.99 (s, 3H, OMe) and 7.46–7.55 (m, 4H). 13C NMR: 12.4 (Me),
62.0 (N-OMe), 123.3 (C-4′), 127.6 (C-2′ and C-6′), 135.5 (C-3′ and C-5′) and 153.5 (C-1). EI-MS (m/z, %):
227 (M+, 100), 212 [(M-15)+, 1], 155 (68), 77 (35), 76 (54) and 75 (61).
2.3.3. (1e)-N-Methoxy-1-(2-methoxyphenyl)ethanimine (2c) [24]
Colourless oil; yield: 79%. IR (film, υ): 2999, 2959, 2938, 2899, 2837, 2816, 1601, 1580, 1493, 1454, 1435, 1366,
1319, 1296, 1273, 1240, 1182, 1125, 1078, 1043, 1028, 883, 808, 756 and 632 cm−1. 1H NMR: 2.18 (s, 3H, Me),
3.82 (s, 3H, ArOMe), 3.82 (s, 3H, N-OMe), 6.90 (d, J= 8.3, 1H, H-3′), 6.95 (dt, J= 1.0 and 7.4, 1H, H-5′) and
7.27–7.36 (m, 2H, H-4′ and H-6′). 13C NMR: 16.0 (Me), 55.4 (ArOMe), 61.7 (N-OMe), 111.0 (C-3′), 120.6
(C-6′), 127.0 (C-5′), 129.5 (C-6′), 130.1 (C-4′) and 156.6 (2C, C-1 and C-2′). EI-MS (m/z, %): 179 (M+, 11),
133 (100), 105 (95) and 77 (75).
2.3.4. (1e)-1-(3,4-Dimethoxyphenyl)-N-methoxyethanimine (2d) [21]
White solid; m.p.: 56–58°C; yield: 84%. IR (KBr, υ): 2961, 1576, 1516, 1464, 1416, 1339, 1277, 1252, 1231,
1175, 1150, 1045, 1020, 918, 866 and 812 cm−1. 1H NMR: 2.19 (s, 3H, Me), 3.88 (s, 3H, OMe-3),* 3.91 (s, 3H,
OMe-4),* 3.97 (s, 3H, N-OMe), 6.83 (d, J= 8.4, 1H, H-5′), 7.13 (dd, J= 2.0 and 8.4, 1H, H-6′) and 7.29 (d,
J= 2.0, 1H, H-2′). 13C NMR: 12.5 (Me), 55.9 (2C, 2 × OMe), 61.8 (N-OMe), 108.6 (C-2′), 110.6 (C-5′), 119.1
(C-6′), 129.4 (C-1′), 149.8 (C-3′),* 150.0 (C-4′)* and 154.2 (C-1). EI-MS (m/z, %): 209 (M+, 100), 194 [(M-15)+,
6], 178 (59) and 137 (41).
2.3.5. 3-[(1E)-N-Methoxyethanimidoyl]aniline (2e) [43]
Colourless oil; yield: 86%. IR (film, υ): 3456, 3441, 3362, 2961, 2936, 1620, 1614, 1580, 1493, 1447, 1368,
1333, 1248, 1049, 920, 870, 785, 692 and 602 cm−1. 1H NMR: 2.18 (s, 3H, Me), 3.63 (s, 2H, NH2), 3.98 (s, 3H,
N-OMe), 6.68 (ddd, J= 0.9, 2.3 and 7.8, 1H, H-4′), 6.97–7.02 (m, 1H, H-2′ and H-6′) and 7.15 (t, J= 8.0, 1H,
H-5′). 13C NMR: 12.8 (Me), 61.8 (N-OMe), 112.4 (C-2′), 116.0 (C-4′), 116.6 (C-6′), 129.3 (C-5′), 137.7 (C-1′),
146.4 (C-3′) and 155.0 (C-1). EI-MS (m/z, %): 164 (M+, 24), 149 [(M-15)+, 4], 133 (20), 118 (18), 108 (21), and
92 (100).
2.3.6. 4-[(1E)-N-Methoxyethanimidoyl]-2-nitrophenol (2f) [30]
White solid; m.p.: 89–92°C; yield: 84%. IR (KBr, υ): 3242, 2940, 1628, 1537, 1323, 1312, 1177, 1040, 883,
845, 764, 687 and 602 cm−1. 1H NMR: 2.21 (s, 3H, Me), 3.94 (s, 3H, N-OMe), 7.14 (d, J= 8.8, 1H, H-5′),
8.0 (dd, J= 2.3 and 8.8, 1H, H-6′), 8,30 (d, J= 2.3, 1H, H-2′) and 10.65 (s, 1H, OH). 13C NMR: 12.0 (Me),
62.2 (N-OMe), 120.1 (C-5′), 122.2 (C-2′), 129.4 (C-1′), 133.3 (C-6′), 134.9 (C-3′), 151.7 (C-1) and 155.5 (C-4′).
EI-MS (m/z, %): 210 (M+, 88), 179 (73) and 133 (100).
2.3.7. (1e)-1-[3,5-bis(Benzyloxy)phenyl]-N-methoxyethanimine (2g)
White solid; m.p.: 89–90°C; yield: 80%. IR (KBr, υ): 2930, 1603, 1580, 1435, 1377, 1360, 1169, 1061, 1043,
1022, 866, 839, 756, 742 and 700 cm−1. 1H NMR: 2.29 (s, 3H, Me), 4.02 (s, 3H, N-OMe), 5.06 (s, 4H, H-1a
and H-1b), 6.64 (t, J= 2.2, 1H, H-4′), 6.94 (d, J= 2.2, 2H, H-2′ and H-6′) and 7.30–7.49 (m, 10H, Ar-H′ and
Ar-H′′). 13C NMR: 12.7 (Me), 62.0 (N-OMe), 70.4 (C-1a and C-1b), 102.8 (C-2′ and C-6′), 105.5 (C-4′), 127.7




(4C, C-2′′, C-6′′, C-2′′′ and C-6′′′), 128.1 (2C, C-4′′ and C-4′′′), 128.6 (4C, C-3′′, C-5′′, C-3′′′ and C-5′′′),
136.8 (2C, C-1′′ and C-1′′′), 138.7 (C-1′), 154.4 (C-1) and 160.0 (2C, C-3′ and C-5′). High resolution mass
spectrum (HRMS) (ESI-TOF, m/z): obsd. 384.1569; C23H2NNaO3 [(M + Na)+] requires 384.1576.
2.3.8. (1E)-N-Methoxy-1-(2-nitrophenyl)ethanimine (2h) [44]
Yellowish oil; yield: 98%. IR (film, υ): 2938, 2820, 1611, 1537, 1346, 1047, 893, 787 and 630 cm−1. 1H NMR:
2.16 (s, 3H, Me), 3.96 (s, 3H, N-OMe), 7.45 (dd, J= 1.5 and 7.5, 1H, H-6′), 7.51 (td, 1H, H-4′), 7.63 (td,
J= 1.3 and 7.5, 1H, H-5′) and 8.00 (dd, J= 1.3 and 8.1, 1H, H-3′). 13C NMR: 16.0 (Me), 62.1 (N-OMe), 124.6
(C-3′), 129.5 (C-4′), 130.6 (C-6′), 133.2 (C-1′), 133.3 (C-5′), 148.0 (C-2′) and 154.7 (C-1). EI-MS (m/z, %): 194
(M+, 6), 179 [(M-15)+, 1], 104 (52), 91 (73) and 77 (100).
2.3.9. 3,5-Dimethoxy-2-[(1E)-N-methoxyethanimidoyl]phenol (2i)
Colourless oil; yield: 87%. IR (film, υ): 2938, 2841, 1643, 1454, 1368, 1215, 1155, 1111, 1051, 905 and
818 cm−1. 1H NMR: 2.26 (s, 3H, Ar-Me), 3.77 (s, 3H, OMe-5),* 3.79 (s, 3H, OMe-3),* 3.95 (s, 3H, N-OMe),
6.02 (d, J= 2.4, 1H, H-4′), 6.14 (d, J= 2.4, 1H, H-6′) and 10.66 (s, 1H, OH). 13C NMR: 16.1 (Me), 55.3 (OMe-
5),* 55.5 (OMe-3),* 62.0 (N-OMe), 91.4 (C-4′), 93.6 (C-6′), 103.6 (C-2′), 158.2 (C-1), 158.4 (C-1′), 160.2 (C-3′)
and 161.7 (C-4′). EI-MS (m/z, %): 225 (M+, 79), 194 (33), 179 (100) and 150 (30). HRMS (ESI-TOF, m/z):
obsd. 226.1077; C11H16NO4 [(M + H)+] requires 226.1079.
2.3.10. 4-[(1E)-N-Methoxypropanimidoyl]benzene-1,3-diol (2j)
Yellowish oil; yield: 89%. IR (film, υ): 3379, 2978, 2938, 1703, 1634, 1614, 1520, 1454, 1250, 1047, 970, 891,
851 and 743 cm−1. 1H NMR: 1.17 (t, J= 7.6, 3H, H-3), 2.77 (q, J= 7.6, 2H, H-2), 3.96 (s, 3H, N-OMe), 5.67
(s, 1H), 6.41 (dd, J= 2.6 and 8.6, 1H, H-4′), 6.46 (d, J= 2.5, 1H, H-2′), 7.27 (d, J= 8.5, 1H, H-5′) and 11.73
(s, 1H). 13C NMR: 11.4 (C-3), 18.8 (Me), 62.3 (N-OMe), 103.9 (C-2′), 107.1 (C-4′), 110.7 (C-6′), 128.8 (C-5′),
157.9 (C-3′), 160.0 (C-1′) and 163.2 (C-1). EI-MS (m/z, %): 195 (M+, 83), 180 [(M-15)+, 1], 164 (33), 135 (100)
and 108 (57). HRMS (ESI-TOF, m/z): obsd. 196.0970; C10H14NO3 [(M + H)+] requires 196.0974.
2.3.11. (1e)-3-Chloro-N-methoxy-1-phenylpropan-1-imine (2k) [45]
Colourless oil; yield: 96%. IR (film, υ): 2938, 2818, 1495, 1445, 1342, 1186, 1049, 899, 694 and 610 cm−1.
1H NMR: 3.23 (t, J= 7.7, 2H, H-2), 3.71 (t, J= 7.7, 2H, H-3), 4.01 (s, 3H, N-OMe), 7.36–7.44 (m, 3H, H-3′,
H-4′ and H-5′) and 7.61–7.69 (m, 2H, H-2′ and H-6′). 13C NMR: 30.6 (C-2), 40.2 (C-3), 62.2 (N-OMe), 126.3
(2C, C-2′ and C-3′), 128.6 (2C, C-3′ and C-5′), 129.4 (C-4′), 135.1 (C-1′) and 154.6 (C-1). EI-MS (m/z, %): 197
(M+, 11), 162 (66), 130 (35), 104 (54) and 77 (100).
2.3.12. N-Methoxy-1,1-diphenylmethanimine (2l) [46]
Colourless oil; yield: 94%. IR (film, υ): 3059, 2936, 2816, 1589, 1494, 1445, 1325, 1165, 1053, 1030, 982, 878,
772 and 696 cm−1. 1H NMR: 4.00 (s, 3H, N-OMe) and 7.30–7.53 (m, 10H, Ar-H and Ar-H′). 13C NMR: 62.5
(N-OMe), 127.9 (2C, C-3′ and C-5′), 128.2 (2C, C-3 and C-5), 128.3 (2C, C-2 and C-4), 128.9 (C-4′), 129.3
(2C, C-2′ and C-6′), 129.3 (C-4), 133.4 (C-1′), 136.5 (C-1) and 156.8 (C-1). EI-MS (m/z, %): 211 (M+, 45), 180
(54) and 77 (100).
2.3.13. (1e)-4-Methylbenzaldehyde O-methyl oxime (2m) [29,47]
Colourless oil; yield: 69%. IR (film, υ): 2990, 2959, 2936, 2899, 1614, 1512, 1462, 1209, 1179, 1055, 955, 918,
854, 814 and 772 cm−1. 1H NMR: 2.37 (s, 3H, Ar-Me), 3.97 (s, 3H, N-OMe), 7.17 (d, J= 8.0, 2H, H-3′ and
H-5′), 7.48 (d, J= 8.0, 2H, H-2′ and H-6′) and 8.04 (s, 1H, H-1). 13C NMR: 21.4 (Ar-Me), 61.9 (OMe), 127.0
(C2′ and C-6′), 129.4 (C-1′, C-2′ and C-3′), 140.0 (C-4′) and 148.6 (C-1). EI-MS (m/z, %): 149 (M+, 73), 134
[(M-15)+, 1], 122 (20), 118 (19), 107 (7), 91 (100), 79 (12) and 77 (15).
2.3.14. (1e)-2-Hydroxy-3-methoxybenzaldehyde O-methyl oxime (2n)
White solid; m.p.: 75–76°C (Lit.: 79–80°C) [48]; yield: 97%. IR (KBr, υ): 2930, 1607, 1464, 1429, 1406, 1356,
1254, 1225, 1049, 916, 777, 731, 689 and 611 cm−1. 1H NMR: 3.89 (s, 3H, OMe), 3.97 (s, 3H, N-OMe), 6.79
(dd, J= 1.9 and 7.7, 1H, H-4′), 6.84 (t, J= 7.7, 1H, H-5′), 6.90 (dd, J= 1.9 and 7.7, 1H, H-6′), 8.14 (s, 1H,
H-1) and 9.86 (s, 1H, OH). 13C NMR: 56.2 (OMe), 62.5 (N-OMe), 113.4 (C-4′), 116.5 (C-1′), 119.4 (C-5′),
122.3 (C-6′), 147.1 (C-3′), 148.2 (C-2′) and 151.1 (C-1). EI-MS (m/z, %): 181 (M+, 100), 166 [(M-15)+, 2], 150
(21), 132 (30) and 108 (26).




2.3.15. (1e)-2,3-Dimethoxybenzaldehyde O-methyl oxime (2o)
White solid; m.p.: 51–52°C (Lit.: 58–59°C) [24]; yield: 92%. IR (KBr, υ): 2936, 1574, 1477, 1464, 1449, 1431,
1342, 1269, 1221, 1045, 997, 918, 795, 758 and 741 cm−1. 1H NMR: 3.83* (s, 3H, OMe-2′), 3.86* (s, 3H, OMe-
3′), 3.97 (s, 3H, N-OMe), 6.91 (dd, J= 1.3 and 8.0, 1H, H-4′), 7.04 (t, J= 8.0, 1H, H-5′), 7.40 (dd, J= 1.3 and
8.0, 1H, H-6′) and 8.40 (s, 1H, H-1). 13C NMR: 55.8 (OMe-3′), 61.5 (OMe-2′), 62.0 (N-OMe), 113.5 (C-4′),
117.8 (C-1′), 124.2 (C-5′), 126.1 (C-6′), 144.5 (C-2′), 148.0 (C-1) and 152.9 (C-3′). EI-MS (m/z, %): 195 (M+,
28), 164 (5) and 149 (100).
2.3.16. 4-[(E)-(Methoxyimino)methyl]benzene-1,3-diol (2p)
White solid; m.p.: 116–118°C (Lit.: 117–118°C) [48]; yield: 97%. IR (KBr, υ): 3995, 3397, 1636, 1614, 1578,
1512, 1437, 1420, 1317, 1298, 1217, 1167, 1125, 1057, 962, 941, 812, 692 and 602 cm−1. 1H NMR: 3.94 (s, 3H,
N-OMe), 5.68 (s, 1H, OH-1), 6.41 (dd, J= 2.4 and 8.3, 1H, H-5′), 6.46 (d, J= 2.4, 1H, H-3′), 7.00 (d, J= 8.3,
1H, H-6′), 8.08 (s, 1H, H-1), 10.13 (s, 1H, OH-3). 13C NMR: 62.4 (N-OMe), 103.4 (C-3′), 107.7 (C-5′), 110.0
(C-1′), 132.2 (C-6′), 151.1 (C-1), 158.4 (C-4′), 159.1 (C-2′). EI-MS (m/z, %): 167 (M+,100), 135 (29), 109 (21),
108 (82) and 94 (34).
2.3.17. (E)-2-Chlorobenzaldehyde O-methyl oxime (2q) [24]
Colourless oil; yield: 92%. IR (film, υ): 2936, 1601, 1472, 1433, 1342, 1209, 1063, 1045, 924, 851, 754, 704, 619
and 602 cm−1. 1H NMR: 3.99 (s, 3H, N-OMe), 7.21–7.32 (m, 2H, H-4′ and H-5′), 7.33–7.39 (m, 1H, H-3′),
7.88 (dd, J= 2.5 and 7.0, 1H, H-6′) and 8.48 (s, 1H, H-1). 13C NMR: 62.2 (N-OMe), 126.9 (C-3′), 127.1 (C-6′),
129.8 (C-4′), 130.0 (C-1′), 130.7 (C-5′), 133.8 (C-2′) and 145.6 (C-1). EI-MS (m/z, %): 169 (M+, 95), 138 (31),
134 (58), 111 (73), 102 (100) and 75 (80).
2.3.18. (E)-2-(Trifluoromethyl)benzaldehyde O-methyl oxime (2r)
Colourless oil; yield: 88%. IR (film, υ): 2968, 2941, 2903, 2822, 1487, 1454, 1360, 1315, 1283, 1171, 1125, 1067,
1049, 1034, 962, 932, 854, 768, 750, 662 and 629 cm−1. 1H NMR: 4.02 (s, 3H, OMe), 7.46* (t, J= 7.5, 1H, H-
4′), 7.54* (t, J= 7.5, 1H, H-5′), 7.67 (d, J= 7.8, 1H, H-3′), 8.06 (d, J= 7.8, 1H, H-6′) and 8.43 (q, J= 2.1,
1H, H-1). 13C NMR: 62.3 (N-OMe), 125.8 (q, J= 5.5, C-3′), 127.2 (C-6′), 128.0 (CF3), 128.4 (C-2′), 129.4
(C-4′), 130.4 (C-1′), 131.9 (C-5′) and 145.2 (C-1). EI-MS (m/z, %): 203 (M+,89), 152 (77), 145 (100), 125 (26)
and 75 (51). HRMS (ESI-TOF, m/z): obsd. 204.0608; C9H9F3NO [(M + H)+] requires 204.0611.
2.3.19. (E)-1-(3,4-Dimethoxyphenyl)propan-2-one O-methyl oxime (2s) [49]
Colourless oil; E/Z diastereomeric mixture (E/Z: 2.8:1); yield: 96%. IR (KBr, υ): 2997, 2938, 2907, 2835, 2816,
1607, 1591, 1514, 1504, 1454, 1445, 1418, 1263, 1236, 1153, 1140, 1055, 1030, 881, 806, 766 and 664 cm−1.
E-isomer: 1H NMR: 1.73 (s, 3H, Me-3), 3.39 (s, 2H, H-1), 3.85 (s, 3H, OMe-4′) 3.86 (s, 3H, OMe-3′),
3.88 (s, 3H, N-OMe) and 6.69–6.82 (m, 3H, H-2′, H-5′ and H6′). 13C NMR: 13.5 (Me), 41.7 (C-2), 55.9
(OMe-2′ and OMe-4′), 61.3 (N-OMe), 111.2 (C-5′), 112.0 (C-2′), 121.0 (C-6′), 129.4 (C-1′), 147.9 (C-4′), 149.0
(C-3′) and 156.8 (C-2). Z-isomer: 1.77 (s, 3H, Me), 3.60 (s, 2H, H-1), 3.85 (s, 3H, OMe-4′), 3.86 (s, 3H,
OMe-3′), 3.88 (s, 3H, N-OMe) and 6.69–6.82 (m, 3H, H-2′, H-5′ and H-6′). 13C NMR: 19.6 (Me-3), 34.9
(C-2), 55.9 (2C, OMe-2′ and OMe-4′), 61.3 (N-OMe), 111.2 (C-5′), 112.0 (C-2′), 121.0 (C-6′), 129.4 (C-1′),
147.9 (C-4′), 149.0 (C-3′) and 156.8 (C-2). EI-MS (m/z, %): 223 (M+,82), 176 (51), 151 (100), 135 (21) and
105 (19).
2.3.20. Methoxy({[(4S)-4-(prop-1-en-2-yl)cyclohex-1-en-1-yl]methylidene})amine
[S-perillaldehyde(E)-O-methyl oxime] (2t) [50]
Colourless oil; yield: 79% (greater than 98% E). [α]D16 = –134.4 (c, 0.84, CHCl3). IR (film, υ): 2936, 2899,
1643, 1454, 1435, 1373, 1179, 1059, 1045, 947, 897 and 667 cm−1. 1H NMR: 1.47 (dddd, 1H, J= 5.4, 11.2,
12.4 and 12.8, H-5ax), 1.74 (s, 3H, H-9), 1.83−1.93 (m, 1H, H-5eq), 2.01−2.09 (m, 1H, H-4), 2.11−2.29 (m,
3H, H-3ax and H-6), 2.47 (ddd, 1H, J= 2.7, 2.3 and 17.3, H-3eq), 3.85 (s, 3H, N-OMe), 4.72 (bs, 1H, H-8a),
4.74 (bs, 1H, H-8b), 5.98 (bdd, 1H, J= 2.4 and 5.2, H-2) and 7.65 (s, 1H, H-10). 13C NMR: 20.7 (H-9), 23.9
(H-5), 26.8 (H-6), 31.3 (H-3), 40.9 (H-4), 61.6 (N-OMe), 109.0 (H-8), 132.6, 134.9, 149.2 and 151.6. EI-MS
(m/z, %): 179 (M+, 2), 164 [(M-15)+, 2], 138 (4), 110 (50), 80 (100) and 68 (44).




2.3.21. (R,E)-2-Methyl-5-(prop-1-en-2-yl)cyclohex-2-enone O-methyl oxime [R-carvone (E)-O-methyl oxime]
(2u) [51]
Colourless oil; yield: 82% (greater than 98% E). [α]D16 = –11.0 (c, 0.15, CHCl3). IR (film, υ): 2965, 2957,
2936, 2924, 2899, 2855, 2837, 2816, 1645, 1441, 1375, 1123, 1051, 908, 891 and 799 cm−1. 1H NMR δ: 1.74 (s,
3H, H-10), 1.79 (bs, 3H, w1/2 = 5.0, H-9), 2.01 (dd, 1H, J = 12.6 and 16.4, H-6ax), 2.03–2.13 (m, 1H, H-4ax),
2.18–2.38 (m, 2H, H-4eq, and H-5), 3.13 (ddd, 1H, J= 1.6, 3.9 and 16.5, H-6eq), 3.90 (s, 3H, N-OMe), 4.79
(m, 2H, w1/2 = 8.7, H-8), and 5.91 (m, 1H, w1/2 = 10.9, H-3). 13C NMR δ: 17.6 (C-10), 20.7 (C-9), 27.8 (C-6),
30.3 (C-4), 40.4 (C-5), 61.7 (N-OMe), 109.8 (C-8), 130.5 (C-2), 132.3 (C-3), 148.0 (C-7) and 156.1 (C-1). EI-MS
(m/z, %): 179 (M+, 20), 164 [(M-15)+, 4], 148 (14), 138 (62), 107 (100), 105 (89), 91 (70) and 80 (51).
2.3.22. (2r,5R,E)-2-Methyl-5-(prop-1-en-2-yl)cyclohexanone O-methyl oxime [1,2-dihydrocarvone (E)-O-methyl
oxime] (2v) [51]
Colourless oil; yield: 96% (greater than 95% E). [α]D16 = –86.0 (c, 0.74, CHCl3); IR (film, υ): 2963, 2930,
2855, 1643, 1447, 1378, 1261, 1051, 905, 880 and 849 cm−1; 1H NMR: 1.10 (d, J= 6.8, 3H, H-10), 1.25 (ddd,
1H, J= 3.2, 12.7 and 24.2, H-4ax), 1.41 (ddd, 1H, J= 3.2, 12.5 and 24.2, H-3ax), 1.58 (t, 1H, J = 13.2, H-6eq),
1.74 (s, 3H, H-9), 1.80–1.90 (m, 1H, H-3eq), 1.90–2.00 (m, 1H, H-4eq), 2.00–2.11 (ddt, 1H, J= 4.0, 12.2 and
13.2, H-5), 2.12–2.24 (m, 1H, H-2), 3.32 (ddd, 1H, J= 2.1, 4.0 and 13.2, H-6), 3.82 (s, 3H, N-OMe) and 4.73
(bs, 2H, w1/2= 3.0, H-8). 13C NMR: 16.4 (C-10), 20.8 (C-9), 29.8 (C-6), 30.9 (C-3), 35.4 (C-4), 37.2 (C-2), 44.8
(C-5), 61.1 (N-OMe), 109.2 (C-8), 148.7 (C-7) and 161.7 (C-1). EI-MS (m/z, %): 181 (M+, 2), 166 [(M-15)+,
2], 149 (2), 125 (8), 109 (13), 97 (50) and 71 (100).
2.3.23. (1e)-N-Hydroxy-1-phenylethanimine (2w)
A stirred mixture of acetophenone (1a, 36 mg, 0.30 mmol), HONH2·HCl (37.5 mg, 0.45 mmol, 1.5 equiv.)
and anhydrous NaOAc (37 mg, 0.45 mmol, 1.5 equiv.) in absolute EtOH (2.5 ml) was treated with
CeCl3·7H2O (8.5 mg, 5 mol%), and the reaction was heated to 50°C in a test tube, without special
protection against atmospheric oxygen. The progress of the reaction was monitored by TLC. After 25 min,
brine (10 ml) was added and the products were extracted with EtOAc (3 × 10 ml). The organic layers were
combined, dried over MgSO4 and concentrated under reduced pressure. The residue was purified by
column chromatography (hexanes : EtOAc) affording 2w (42.5 mg, 95%), as a white solid, m.p.: 56–58°C
(Lit.: 55–57°C) [52]. IR (KBr, υ): 3316, 2926, 1445, 1371, 1302, 1080, 1009, 928, 762 and 692 cm−1; 1H NMR:
2.32 (s, 3H, Me), 7.45–7.34 (m, 3H, H-3′, H-4′ and H-5′), 7.69–7.59 (m, 2H, H-2′ and H-6′) and 9.45 (s, 1H,
OH); 13C NMR: 12.4 (Me), 126.0 (C-2′ and C-6′), 128.6 (C-3′ and C-5′), 129.3 (C-4′), 136.5 (C-1′) and 156.0
(C-2). EI-MS (m/z, %): 135 (M+, 61), 120 [(M-15)+, 3], 118 (12), 106 (20), 103 (19), 94 (27) and 77(100).
3. Results and discussion
At the outset of the study, based on previous experience [40] and on the literature regarding non-
promoted methoximations, the development of an optimal protocol was sought, with acetophenone (1a)
as the chosen model starting material, in EtOH as solvent. Trial and error experiments, which included
heating from room temperature to reflux, revealed that incubating the reaction at 50°C provided the most
convenient conversions in short times and under mild conditions.
On the other hand, progressive reduction of the excess of methoxylamine (range 2.5–1.1 equiv.)
exposed that 1.5 equiv. of each, MeONH2·HCl and the base, were required for optimal results. Lowering
the amount of MeONH2·HCl to 1.2 equiv. or below afforded either unfinished transformations or long
reaction times. Hence, warming the reaction at 50°C in the presence of 1.5 equiv. each methoxylamine
hydrochloride and the base were set as the initial conditions for further improvements.
Then, the qualitative and quantitative effects of the addition of catalytic amounts of different Lewis
acids were explored, using Ba(II), Cd(II), Ce(III), Cu(I), Cu(II), Fe(II), Fe(III), La(III), Mn(II), Mn(III), Ni(II),
Sc(III) and Zn(II), salts, at a level of 5 mol%.
The transformations were monitored by GC-MS, employing anisole as internal standard, with the
results detailed in table 1. This enabled us to observe that, in the absence of a promoter, the reaction
afforded only 21% yield of the expected methoxime 2a after 40 min (entry 1) and required 12 h to reach
completion. It was also evident that Ba(OAc)2·H2O was ineffective under these conditions (entry 2), with
results analogous to the non-promoted process.




Table 1. Screening of Lewis acids as promoters for the methoximation of acetophenone (1a).a
yield (%)b
entry no promoter 20 min 30 min 40 min
1 — 10 17 21
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2 Ba(OAc)2·H2O 12 16 20
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
3 CuI 20 26 30
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
4 Cu(OAc)2·H2O 18 25 31
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
5 La(NO3)3·6H2O 18 24 33
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
6 FeSO4·7H2O 27 33 42
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
7 FeCl3 25 37 43
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
8 Mn(OAc)3·2H2O 29 36 44
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
9 CdCl2·xH2O 31 39 47
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
10 Sc(TfO)3 34 51 65
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
11 ZnI2 53 79 100
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
12 MnSO4·4H2O 83 96 100
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
13 MnCl2·4H2O 80 100 100
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
14 CeCl3·7H2O 89 100 100
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
15 CeCl3 (anhydrous) 100 100 100
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
aReaction conditions: acetophenone (0.3 mmol, 1.0 equiv.), MeOHNH2·HCl (1.5 equiv.), NaOAc (1.5 equiv.), promoter (5 mol%), absolute EtOH (2.5 ml),
anisole (internal standard, 0.3 mmol), 50°C.
bYields were determined by GC-MS analysis, employing anisole as internal standard.
Copper salts performed only slightly better; however, regardless of their different solubility and
oxidation state, the outcome was similar. At 40 min CuI afforded only 30% yield of the product 2a
(entry 3), whereas Cu(OAc)2·H2O gave the methoxime in 31% yield (entry 4), both being found to be
not viable to favour this transformation. Interestingly, an undisclosed copper salt supported on silica gel
has been recently proposed as promoter for the preparation of oximes derived from aromatic aldehydes,
in reactions taking 2–3 h to reach completion [53].
The use of La(NO3)3.6H2O gave similar results (entry 5), while the tested iron salts furnished
approximately 10% increment in the yields (entries 6 and 7); an analogous behaviour was observed in
the reactions promoted by Mn(OAc)3·2H2O and CdCl2·xH2O, which resulted in 44% and 47% of 2a,
respectively, at the 40 min check time (entries 8 and 9).
On the other hand, addition of Sc(OTf)3 caused a performance jump to 65% yield at the end of the
standard 40 min period (entry 10), while the reactions run under promotion by ZnI2, MnSO4·4H2O
MnCl2·4H2O and CeCl3·7H2O afforded quantitative yields of the methoxime 2a at this time-point
(entries 11–14).
Interestingly, despite the importance of the counterions in Lewis acid-mediated carbonyl activation
on the outcome of the thus triggered transformations [54], the performances of the reactions promoted
by MnSO4·4H2O and MnCl2·4H2O were similar.
Moreover, inspection of the reaction yields at earlier times, revealed that the behaviour of
MnSO4·4H2O, MnCl2·4H2O and CeCl3·7H2O was quite similar and better than ZnI2, with CeCl3·7H2O
slightly outperforming the manganous salts, when the reaction was checked at the 20 min mark (89%
versus 80% for MnCl2·4H2O and 83% for MnSO4·4H2O).
Notably, the superior promotion effects observed for CeCl3·7H2O are fully consistent with those
reported in other transformations involving carbonyl moieties [41,55,56]. Furthermore, anhydrous
CeCl3 [57] performed even better than the hydrate at short reaction times (entry 15). However, because




Table 2. Optimization of the reaction conditions for the methoximation of acetophenone (1a).a
yield (%)b
entry no. solvent base (1.5 equiv.)
promoter load
(mol%) 20 min 30 min 40 min
1 PhMe NaOAc 5 0 0 0
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2 CHCl3 NaOAc 5 0 0 0
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
3 MeCN NaOAc 5 0 0 0
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
4 dioxane NaOAc 5 0 0 0
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
5 THF NaOAc 5 11 19 30
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
6 MeOH NaOAc 5 77 84 91
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
7 i-PrOH NaOAc 5 64 65 75
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
8 t-BuOH NaOAc 5 81 82 89
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
9 EtOH NaOAc 5 89 100 100
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
10 EtOH 96% NaOAc 5 89 99 100
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
11 EtOH 80% NaOAc 5 73 93 99
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
12 EtOH Et3N 5 74 92 100
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
13 EtOH NaHCO3 5 83 93 100
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
14 EtOH K2HPO4 5 84 99 100
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
15 EtOH K2CO3 5 73 84 90
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
16 EtOH NaOAc 2 24 37 47
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
17 EtOH NaOAc 4 74 92 100
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
18 EtOH NaOAc 6 91 100 100
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
19 EtOH NaOAc 8 93 100 100
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
aReaction conditions: ketone 1a (0.3 mmol, 1.0 equiv.), MeONH2·HCl (1.5 equiv.), solvent (2.5 ml), 50°C.
bYields determined by GC-MS analysis, with anisole as internal standard.
the eco-friendly CeCl3·7H2O is inexpensive, commercially available and easier to handle, it was selected
for further optimization of the model reaction.
The nature of the reaction solvent was also optimized (table 2, entries 1–11), with the use of
CeCl3·7H2O as promoter in the presence of NaOAc. It was observed that the transformation did not
proceed at all in PhMe, CHCl3, MeCN and dioxane (entries 1–4), whereas it afforded a meagre 30% yield
of 2a in THF, after 40 min (entry 5).
Oppositely, alcoholic solvents (MeOH, EtOH, iPrOH, tBuOH) proved to be suitable media to achieve
moderate-to-excellent yields of the product (64–89% after 20 min, entries 6–9). Probably, this is owing to
the better solubility of all the reactants in alcoholic solvents and to their potential interaction with the
promoter. Interestingly, it was shown that CeCl3 forms a dimeric adduct with MeOH, [Ce2Cl6(MeOH)8]
that persists in solution and the corresponding ethanol adduct can also be prepared [58,59].
Hence, EtOH emerged from these experiments as the most advantageous solvent alternative (entry
9). It was also found that the reactions can also be carried out without special protection against oxygen.
However, the absolute grade solvent proved to be more efficient than its mixtures (up to 20% v/v)
with water (entries 9–11). In these cases, it was observed that the presence of H2O did not hinder the
transformation, but it seemed to slightly lower the reaction rate.
On the other hand, the aptitude of mild bases (NaHCO3, K2CO3, K2HPO4 and Et3N) other than
NaOAc, to free the methoxime base was also evaluated (entries 12–15) in EtOH. However, despite their





excellent performances, especially in the case of K2HPO4 (99% at 30 min and 100% at 40 min, entry 14),
none of them surpassed that of NaOAc.
In addition, when 0.15 M solutions of MeONH2·HCl in EtOH (2.5 ml) were treated with NaOAc (0.90,
1.0 and 1.1 equiv.) and diluted with water (5.0 ml), they exhibited essentially the same pH values (4.83,
4.89 and 4.91, respectively), confirming the robustness of the method. Under these conditions Ce(III) is
stable in solution and it has been shown that oximation reactions are slow and their rate has a maximum
between pH 4 and 5 [60]. Accordingly, NaOAc was selected as the added base for further experiments.
Finally, the load of the promoter was analysed, in the range 2–8 mol% (entries 9, 16–19), observing
that the product yield was quantitative at the 30 min checkpoint with loads of at least 5 mol% (entries 9,
18 and 19). However, while it was found that the reaction was complete in 40 min at a 4 mol% promoter
level, it was also concluded that loads above 5 mol% did not produce any substantial improvement at
the 20 min control time. Therefore, the latter level was chosen as the optimum.
The resulting protocol (MeONH2·HCl and NaOAc (1.5 equiv. each) and 5 mol% CeCl3.7H2O in EtOH
at 50°C) proved to be mild and respectful towards sensitive compounds, while remaining a highly
discriminating condition against the non-catalysed process.
Next, the scope of the optimized methodology was explored, employing various aromatic ketones
and aldehydes with different substituents and substitution patterns (table 3). In general, very good-
to-excellent yields were obtained at 50°C with both, aromatic ketones (entries 1–12) and aldehydes
(entries 13–18), usually taking place in short reaction times. Being more reactive, the best results were
achieved with the latter ones, in which cases the transformations were also completed in comparatively
shorter times.
Further analysis of the results revealed that no significant effects were detected owing to the presence
of either electron withdrawing (entries 2, 6, 8, 17 and 18) or electron donating (entries 3–5, 7, 9 and 10)
groups attached to different positions of the aromatic ring. However, the nitro derivatives of entries 6
and 8 reacted at a lower rate, taking longer times to reach completion.
The reaction conditions also proved to be compatible with ortho-substituents (entries 3, 8–10
and 14–18), without substantial loss of performance, except that compounds exhibiting bulky ortho-
substituents (entries 8, 9 and 12) and ketones displaying ortho hydroxy groups (entries 9 and 10) were
methoximated in good yields, at the expense of rather longer reaction periods.
In the case of 2-hydroxyketones, some starting material was recovered at the end of the reaction
period. Presumably, this may be a result of the presence of a hydrogen bond between the phenol and the
carbonyl moieties. The transformation was also viable in the presence of free phenols and free amines
in different positions (entries 5, 6, 9, 10, 14 and 16) and took place with aromatic ketones other than
acetophenones (entries 10–12).
On the other side, the performances of the reactions with 3,4-dimethoxyphenylacetone (entry
19) [61,62], perillaldehyde (entry 20) [63], carvone (entry 21) [64,65] and (+)-1,2-dihydrocarvone (entry
22) [65] confirmed that the transformation can also take place efficiently with aliphatic/alicyclic
aldehydes and ketones, even in the presence of some steric hindrance and double bond conjugation.
The conjugate addition of hydroxylamine derivatives to α,β-unsaturated carbonyls is a serious side
reaction in certain systems, leading sometimes to undesired products [49,50,66]. Lewis acids have
been found to promote carbonyl activation, favouring this process [51,67,68]. Fortunately, however,
no products arising from conjugate addition were observed in the experiments of entries 20 and 21,
suggesting that the reaction conditions are mild enough to prevent this reaction, and that carbonyl
methoximation is faster than the Michael addition. The methoxime product, being less reactive, is less
likely to undergo a conjugate addition.
In addition, it was observed that the Ce(III)-promoted reaction was also successful with
hydroxylamine. When acetophenone was used as substrate, 95% yield of the expected oxime 2w was
obtained after 25 min (entry 23); in comparison, the non-catalysed process took over 140 min to reach
completion under the same conditions.
The structures of the different products were assessed by their melting points, as well as by IR and
NMR (1H and 13C) spectroscopy, being all in full agreement with their proposed structures and with
the corresponding literature data. Not unexpectedly, in many cases they were obtained as mixtures of
anti/syn (E/Z) isomeric compounds that could not be separated chromatographically.
The major products were assigned as the anti-isomers on the basis of comparative analysis of their
1H NMR spectral data and the known tendency of acetophenone oximes to preferentially adopt the
anti-configuration [69]. Furthermore, most of the methoximes are known compounds and were chosen
with the purpose of comparing the performance of the proposed cerium(III)-promoted transformation
with previous results (cf. electronic supplementary material).





Table 3. Scope of the CeCl3·7H2O-promoted methoximation reaction.a
entry no. R1 R2 R3 R4 R5 R6 time (h) prod. no. yield (%)b
1 Me H H H H H 0.5 2a 100
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2 Me H H Br H H 0.67 2b 80
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
3 Me OMe H H H H 1.0 2c 79
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
4 Me H OMe OMe H H 1.0 2d 84
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
5 Me H NH2 H H H 0.4 2e 86
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
6 Me H NO2 OH H H 2.0 2f 84
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
7 Me H OBn H OBn H 1.1 2g 80
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
8 Me NO2 H H H H 18 2h 98
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
9 Me OH H OMe H OMe 18d 2i 87
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
10 CH2Me OH H OH H H 18d 2j 89
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
11 CH2CH2Cl H H H H H 0.67 2k 96
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
12 Ph H H H H H 18 2l 94
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
13 H H H Me H H 0.33 2m 90
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
14 H OH OMe H H H 0.4 2n 97
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
15 H OMe OMe H H H 0.33 2o 92
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
16 H OH H OH H H 0.4 2p 97
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
17 H Cl H H H H 0.67 2q 92
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
18 H CF3 H H H H 0.4 2r 88
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
19 0.4 2s 96
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
20 0.6 2t 79
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
21 1.33 2u 82
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
22 0.4 2v 96
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
23c 0.4 2w 95
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
aReaction conditions: aldehyde or ketone (0.3 mmol, 1.0 equiv.), MeONH2·HCl (1.5 equiv.), CeCl3·7H2O (5 mol%), NaOAc (1.5 equiv.), EtOH (2.5 ml), 50°C.
bIsolated product yields after column chromatography.
cThe reaction was performed with 1.5 equiv. HONH2·HCl.
dThe reaction was terminated at the informed time. Starting material left.
In this analysis it was observed that, in general, the proposed alternative was advantageous and
outperformed the previously reported methodologies, providing improved yields of the products
under milder conditions, in shorter reaction times and/or at the expense of lower excess of reagents
(MeONH2·HCl and base).
Although the exact mechanistic details of the reaction remain unknown, a catalytic cycle, like that
depicted in scheme 1, can be drawn by analogy with similar transformations, such as other Lewis acid-
mediated protection of ketones and aldehydes.





Scheme 1. Proposed reaction mechanism for the catalytic cycle of the CeCl3·7H2O-promoted methoximation of aromatic aldehydes and
ketones.
The reaction can be assumed to take place through a stepwise process. In the first stage, the
oxophilic promoter coordinates with the carbonyl moiety of 1 to afford the activated intermediate i.
This intermediate is more likely than the starting carbonyl derivative to undergo nucleophilic attack by
the nitrogen of the methoxylamine and furnish intermediate ii in a second step.
In the next phase, a proton transfer within this intermediate would generate intermediate iii, which
is prone to suffer dehydration, with concomitant deprotonation, release of the methoxime product 2 and
regeneration of the promoter. Most probably, the steps from 1 to iii are readily reversible under the mild
reaction conditions, whereas once formed compound 2, it is less likely that it could revert to the starting
carbonyl derivative 1 under the same conditions, owing to the relative hydrolytic stability of the oxime
ethers [70].
4. Conclusion
In conclusion, we have developed an expeditious and efficient CeCl3·7H2O-based catalytic method for
the methoximation of aromatic aldehydes and ketones under mild conditions and demonstrated that the
system is also operative on their aliphatic counterparts and for the synthesis of acetophenone oximes.
This efficacious reagent reduced substantially the reaction times, the amounts of MeONH2·HCl and base
required, and afforded very good-to-excellent product yields.
The transformation takes place with an eco-friendly promoter and a sustainable solvent. Further, it
was observed that there is no need to employ the anhydrous reagent nor an anhydrous solvent; however,
for shorter reaction times, the use of CeCl3·7H2O in absolute EtOH is preferred.
This catalytic system proved to be robust, and capable to accept a wide variety of aldehydes and
ketones. It is also tolerant to electron poor and electron rich substrates, as well as those with some steric
demand; in the latter case, at the expense of longer reaction times. These are promising results in the field
of synthesis of oximes, which suggest they will find wide use in multistep syntheses of more complex
molecules.
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